Course: Proposed Rule on Profits and Related Basis Adjustments based on this document from the Federal Register: https://www.govinfo.gov/content/pkg/FR-2024-12-02/pdf/2024-27227.pdf This document contains proposed regulations regarding previously taxed earnings and...
FDA’s Final Rule on Nonprescription Drugs with ACNU
Discover how the FDA’s final rule on nonprescription drugs with Additional Conditions for Nonprescription Use (ACNU) is transforming the pharmaceutical landscape. This course covers application and labeling requirements, postmarketing reporting, and the dual marketing of prescription and nonprescription drugs, enhancing consumer access to safe medications.
In this course you will learn the following:
* Understand the purpose and scope of the final rule on nonprescription drug products with an ACNU.
* Identify the key requirements for applications, labeling, and postmarketing reporting.
* Recognize the consequences of non-compliance with the final rule.
* Implement actionable steps to ensure compliance with the new regulations.
Additional information
Federal Register Title | Nonprescription Drug Product With an Additional Condition for Nonprescription Use. Document Number: 2024-30261 |
---|---|
Course SKU | FR-24-1116-1 |
Why This Course Is Important | Without this course, you might struggle to navigate the new FDA requirements for marketing nonprescription drugs with ACNU, potentially risking non-compliance and enforcement actions. |